News
November 15, 2022 | Duke Research Blog
Charlie and Pratiksha are among "Most Cited Scientists"
November 3, 2022 | Nature Biotechnology
Tune Therapeutics is one of Nature Biotechnology's academic spinouts of 2021!
April 28, 2022 | Gilbert Family Foundation
Gersbach Lab is awarded funding from the Gilbert Family Foundation to develop genome editing therapies for Neurofibromatosis
March 9, 2022 | Nature Biotechnology
Nature Biotech highlights the therapeutic potential of epigenome editing
December 2, 2021 | Tune Therapeutics, Inc.
Tune Therapeutics launches to develop a new class of gene and cell therapies based on epigenomic control.
November 16, 2021 | Duke Research Blog
Charlie is recognized as 2021 Highly Cited Researcher
September 9, 2021 | Duke CAGT
Duke recieves two new NIH-funded centers to explore genomic variation
August 3, 2021 | Duke CAGT
Our work developing new mouse models for CRISPR-based epigenome editing is published in Nature Methods
Matt and Keith's paper on new mice for CRISPR-based epigenome editing is published in Nature Methods! Read more about the work here.
July 10, 2021 | Duke Today
Charlie Awarded Distinguished Professorship
May 5, 2021 | Duke GCB News
New Collaborative Grant to Study Genetics of Neuropsychiatric Disorders
November 18, 2020 | Duke BME News
Charlie is Recognized as 2020 Highly Cited Researcher
September 24, 2020 | GCB News
NIH Grant Creates First Duke Center of Excellence in Genome Sciences
For the first time at Duke, the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, is awarding a Center of Excellence in Genome Science (CEGS) grant, to a group of Duke researchers, providing $14 million of research support over [...]
April 14, 2020 | Duke Research Blog
Gersbach lab research highlighted by Vice President of Research
Dr. Carin reflects on how Duke's fundamental research can turn viruses into marvels.
January 2, 2020 | Pratt News
Duke Researchers Garner Over $6 Million in NIH Funding to Fight Genetic Diseases
Collaborative work using CRISPR genome editing to address the burden of genetic neuromuscular diseases flourishes across Duke.
November 19, 2019 | Duke Today